(Reuters) - The United States sued a unit of the drugmaker Mallinckrodt Plc on Tuesday, accusing it of defrauding Medicaid out of hundreds of millions of dollars as a result of “meteoric” price increases for its biggest-selling drug, Acthar Gel.
Trending:
U.S. sues Mallinckrodt, accuses drugmaker of defrauding Medicaid